Vident Advisory’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.95M | Sell |
55,371
-31,147
| -36% | -$3.35M | 0.07% | 235 |
|
|
2025
Q1 | $8.73M | Sell |
86,518
-15,387
| -15% | -$1.55M | 0.13% | 154 |
|
|
2024
Q4 | $9.1M | Buy |
101,905
+8,292
| +9% | +$741K | 0.16% | 138 |
|
|
2024
Q3 | $7.84M | Buy |
93,613
+69,647
| +291% | +$5.84M | 0.2% | 99 |
|
|
2024
Q2 | $1.85M | Buy |
23,966
+4,833
| +25% | +$372K | 0.05% | 399 |
|
|
2024
Q1 | $1.31M | Buy |
19,133
+2,205
| +13% | +$151K | 0.03% | 498 |
|
|
2023
Q4 | $979K | Buy |
16,928
+959
| +6% | +$55.4K | 0.02% | 563 |
|
|
2023
Q3 | $843K | Buy |
+15,969
| New | +$843K | 0.03% | 561 |
|